Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
112.50    0.00 (0.00%)
Bid:
110.00
Ask:
115.00
Spread: 5.00 (4.545%)
Market Cap: £67.68m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Director/PDMR Shareholding

8 Jun 2009 17:28

RNS Number : 5627T
Intercede Group PLC
08 June 2009
 

Intercede Group plc ("Intercede" or the "Company")

Directors' Holdings in Company

And

Notification of Interest

Further to the conversion of loan notes to ordinary shares (the "Conversion") and the resultant increase in the Company's issued share capital announced on 1 June 2009, the Company has been advised of changes to the notifiable holdings of directors and significant shareholders as set out below:

The Company was notified on 5 June 2009 by the Trustees of The Azalia Trust, being persons connected with Jacques Tredoux, a director of Intercede, pursuant to DTR 3.1 and DTR 5.1, that on 1 June 2009 The Azalia Trust indirectly acquired through controlled undertakings an aggregate of 5,740,485 ordinary shares of 1p each in the Company as a result of electing to convert the Trust's indirect interests in convertible loan notes at the conversion prices of 20p and 15p per share. Following the conversion, the Trust now has an aggregate indirect holding of 11,063,128 ordinary shares, representing 22.96% of the issued ordinary share capital of the Company.

The controlled undertakings of The Azalia Trust with disclosable holdings are:

Name of undertaking

Number of shares acquired as a result of Conversion

Existing shareholding prior to Conversion

Percentage holding following Conversion

Friskney Enterprises Limited

1,800,545

0

3.74%

Ferrybridge Enterprises Limited

1,854,907

0

3.85%

React Invest Limited*

2,085,033

1,344,683

7.12%

* React Invest Limited hold a further 402,448 shares which are not for the beneficial interest of Azalia Trust giving a total shareholding of 3,832,164 shares (7.95%).

The Company was notified on 5 June 2009 by the Trustees of The Woodcock Trust, being persons connected with Jacques Tredoux, pursuant to DTR 5.1.2 (2), that as a result of the increase in the issued share capital of the Company, The Woodcock Trust is now indirectly holding 3.04% of the Company's issued share capital, having previously held 4.31% of the same. The 1,463,216 shares in which the Trust is interested are registered in the name of Pershing Keen Nominees Limited, which is a nominee of Angus Investment Holdings Limited ("Angus"). Angus is controlled by The Woodcock Trust, of which Jacques Tredoux and his wife and children are members of the class of discretionary beneficiaries.

The holdings of the directors of the Company following the Conversion are as set out in the table below:

Director

No. of shares held

% of issued share capital

R A Parris

6,472,232

13.43%

A M Walker

1,248,077

2.59%

R Hoggarth

168,721

0.35%

J S Sikorski

106,686

0.22%

The Azalia Trust and The Woodcock Trust have an aggregate indirect holding of 12,526,344 ordinary shares in the Company (26.00%). Although Jacques Tredoux does not have any direct holdings in the ordinary shares of the Company, he and his wife and children are members of the class of discretionary beneficiaries under the Trusts.

The Company wishes to clarify other significant shareholdings as at 5 June 2009 resulting from the Conversion and increase in its issued share capital to 48,178,005 ordinary shares.

Shareholder

No. of shares held

% of issued share capital

Anjar International Limited

3,241,631

6.73%

Plastic Technologies Ltd

3,147,436

6.53%

Barclayshare Nominees Limited

1,655,661

3.42%

Cogefin (Bermuda) Limited

1,582,541

3.28%

Hargreave Hale Nominees Limited

1,568,788

3.26%

For further information please visit www.intercede.com or contact:

Andrew Walker Intercede Group plc 01455 558 111

Charles Cunningham FinnCap 020 7600 1658

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQVLFBKQBLBBD
Date   Source Headline
15th Sep 20212:09 pmRNSResult of AGM
15th Sep 20217:00 amRNSMultiple Customers choose to Upgrade MyID
20th Jul 20217:00 amRNSIntercede achieves FIDO2 certification
5th Jul 20217:00 amRNSConnect Partner Programme & Q1 Contract Wins
15th Jun 20218:26 amRNSIssue of Equity
8th Jun 20217:00 amRNSFinal Results
2nd Jun 202110:09 amRNSInvestor Presentation
10th May 20217:00 amRNSShare Incentive Plan
7th Apr 20217:00 amRNSTrading Update & Appointment of Auditor
1st Apr 202110:30 amRNSReceipt of $3.4m Order
10th Mar 20217:00 amRNSShare Incentive Plan
23rd Feb 20217:00 amRNSAmendment to LTIP
22nd Feb 20214:10 pmRNSHolding(s) in Company
16th Feb 20217:00 amRNSCLN Conversion to Equity
12th Feb 20217:00 amRNSHolding(s) in Company
8th Feb 202112:40 pmRNSHolding(s) in Company
4th Feb 20217:00 amRNSCLN Call & Issue of Equity
11th Jan 20217:00 amRNSNew Contract Win
5th Jan 202111:00 amRNSCLN Conversion to Equity
4th Jan 202110:40 amRNSHolding(s) in Company
22nd Dec 20207:00 amRNSNew Contract Win
24th Nov 20207:00 amRNSHalf-year Report
17th Nov 20207:00 amRNSContract Win: Follow-on Purchase Order
12th Nov 20207:00 amRNSInvestor Presentation
8th Oct 20207:01 amRNSIntercede join the FIDO Alliance
8th Oct 20207:00 amRNSTrading Update
16th Sep 20203:40 pmRNSResult of AGM
20th Aug 20207:05 amRNSContract Win - Initial Progress Order
5th Aug 20202:01 pmRNSHolding(s) in Company
30th Jul 20207:00 amRNSContract Win
2nd Jun 20207:00 amRNSFinal Results
12th May 20207:00 amRNSShare Incentive Plan
20th Apr 202010:02 amRNSDirector/PDMR Shareholding
14th Apr 20207:00 amRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSTrading Update
3rd Apr 20205:07 pmRNSShare Incentive Plan
31st Mar 20207:00 amRNSReceipt of $4.6m Order
28th Feb 20207:00 amRNSShare Incentive Plan
26th Feb 20209:50 amRNSShare Incentive Plan
25th Feb 20207:00 amRNSShare Incentive Plan
12th Feb 202011:22 amRNSShare Award
25th Nov 20197:00 amRNSHalf-year Report
7th Oct 20197:00 amRNSTrading Update
30th Sep 20197:00 amRNSDirector/PDMR Shareholding
18th Sep 20196:30 pmRNSResult of AGM
16th Sep 20193:56 pmRNSPosting of Annual Report & Notice of AGM
17th Jun 20197:00 amRNSAppointment of Non-Executive Director
5th Jun 20197:00 amRNSFinal Results
8th Apr 20197:00 amRNSSale of Property
2nd Apr 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.